Axon Enterprise, Inc (NASDAQ:AXON – Get Free Report) insider Elizabeth Reid Coughlin sold 1,554 shares of the firm’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the completion of the transaction, the insider owned 34,024 shares of the company’s stock, valued at approximately $16,501,640. The trade was a 4.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Axon Enterprise Stock Performance
Shares of AXON opened at $447.59 on Thursday. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91. The company has a 50-day moving average of $409.55 and a two-hundred day moving average of $490.06. The stock has a market cap of $36.08 billion, a price-to-earnings ratio of 179.76, a PEG ratio of 8.23 and a beta of 1.45. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The business had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm’s revenue was up 33.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.47 earnings per share. On average, equities research analysts expect that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.
Institutional Trading of Axon Enterprise
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on AXON shares. TD Cowen reduced their price target on shares of Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Citizens Jmp reduced their price target on shares of Axon Enterprise from $825.00 to $700.00 and set a “market outperform” rating for the company in a research report on Thursday, May 7th. The Goldman Sachs Group set a $535.00 price target on shares of Axon Enterprise in a research report on Thursday, May 7th. Royal Bank Of Canada reduced their price target on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research report on Wednesday, February 25th. Finally, Barclays reduced their price target on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a research report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $712.75.
Read Our Latest Stock Report on Axon Enterprise
Axon Enterprise News Summary
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Axon’s Connected Devices business is showing renewed momentum, with revenue up 33% as demand accelerated for TASER 10, Axon Body 4, and platform solutions. That reinforces the company’s growth story and suggests upside if product adoption continues. AXON’s Connected Devices Growth Picks Up: More Upside to Come?
- Positive Sentiment: Analyst coverage remains favorable, with reports saying the average brokerage recommendation is a Buy / Moderate Buy and one major bank maintained a $705 price target. That kind of support can help investor confidence, especially after a recent selloff. Analyst Reiterates Buy on AppLovin, Maintains $705 Price Target on Axon-Driven Long-Term Growth Outlook
- Neutral Sentiment: Articles revisiting whether investors should trust brokerage ratings are more commentary than catalyst, so they are unlikely to move the stock on their own. AXON’s Connected Devices Growth Picks Up: More Upside to Come?
- Negative Sentiment: Insider sales by executive Patrick Smith and CRO Cameron Brooks may weigh on sentiment, even though the transactions were disclosed under pre-arranged trading plans. Investors often view insider selling cautiously when a stock has already been volatile. Patrick Smith Sells 20,000 Shares of Axon Enterprise (NASDAQ:AXON) Stock
- Negative Sentiment: Competitive pressure may be increasing as Motorola Solutions moves further into counter-drone and public safety technology, potentially challenging Axon’s future expansion in adjacent markets. Axon Enterprise Weighs Motorola Counter Drone Deal For Public Safety Future
Axon Enterprise Company Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Stories
- Five stocks we like better than Axon Enterprise
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
